Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.62
-0.15 (-2.22%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of $435.64 million as of October 16, 2026. Its market cap has increased by 42.44% in one year.
Market Cap
435.64M
Enterprise Value
331.34M
1-Year Change
42.44%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from $61.62M to $435.64M, an increase of 607.00%. That is a compound annual growth rate of 41.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 435.64M | 14.28% |
| Dec 31, 2025 | 381.21M | 241.41% |
| Dec 31, 2024 | 111.66M | 0.72% |
| Dec 29, 2023 | 110.86M | 90.37% |
| Dec 30, 2022 | 58.23M | 111.19% |
| Dec 31, 2021 | 27.57M | -55.25% |
| Mar 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 457.14M |
| Arvinas | 455.74M |
| Allogene Therapeutics | 452.59M |
| Oculis Holding AG | 450.03M |
| BlossomHill Therapeutics | 443.08M |
| Prothena Corporation | 428.66M |
| Altimmune | 427.94M |
| MapLight Therapeutics | 427.93M |